Ethyl 6-bromoimidazo[1,5-a]pyridine-1-carboxylate, 95.0%, 1g

Tris[4-(2-thienyl)phenyl]amine>98.0%(GC)1g

2-Amino-5-(trifluoromethoxy)benzonitrile, 95.0%, 1g

1-Adamantanemethylamine, 95.0%, 250mg

3-(piperidin-4-yloxy)pyridine dihydrochloride, 95.0%, 500mg

Methyl 5-chloro-2-nitrobenzoate, 95.0%, 25g

(R)-3-(Trifluoromethyl)pyrrolidin-3-ol, 98%, 1g

4-(2-METHYLPHENOXY)PIPERIDINE HCL, 95.0%, 1g

1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(6-{[({amino[(4-chlorophenyl)amino]methylidene}amino)methanimidoyl]amino}hexyl)methanimidamide; bis(acetic acid), 10g

Sodium benzo[d]isoxazol-3-ylmethanesulfonate, 95.0%, 10g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(3-((tert-butoxycarbonyl)amino)propyl)glycine, 97%, 1g

Vinyl butyrate (stabilised with MEHQ), 97.0%, 25ml

methyl 2-hydroxy-4-(3-methylphenyl)-4-oxobut-2-enoate, 95%, 5g